🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06936904
Recruiting Not applicable

Different Injection Speed on Local Anaesthetic Spread of ESPB

NCT06936904 · tracked via the Priya Life Science China tracker
Sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Not applicable
Started
2025-04-21
Last updated
2025-05-22

Condition(s) studied

Erector Spinae Plane Block

Investigational drug(s) / intervention(s)

injection speed

injection speed: Patients undergoing CT-guided lung nodule localization were selected for the study, and ultrasound-guided erector spinae plane block was performed before surgery with different injection speed.

Study summary

The aim of this clinical trial is to investigate the effect of different injection speeds on the spread of local anesthetic during ultrasound-guided erector spinae plane block (ESPB) in patients undergoing CT-guided lung nodule localization. The primary question addressed is whether a high injection speed (30 ml delivered within 30 seconds) produces a different local anesthetic distribution compared with a lower injection speed (30 ml delivered within 180 seconds).

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: Patients scheduled for CT-guided lung nodule localization under local anesthesia will be selected 1. aged 18-80 years 2. BMI 18-30 kg/m² 3. ASA classification I-III Exclusion Criteria: 1. Allergy to the study drug or to local anesthetics 2. History of opioid abuse 3. Previous infection at the ESPB or PVB puncture site 4. Peripheral neuropathy 5. Dysfunction of blood coagulation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nanjing First Hospital Nanjing Jiangsu Recruiting

More Nanjing First Hospital, Nanjing Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06936904 on ClinicalTrials.gov ↗ ← All trials in China